Atomic structure of a thermostable subdomain of HIV-1 gp41.Tan, K., Liu, J., Wang, J., Shen, S., Lu, M.
(1997) Proc.Natl.Acad.Sci.USA 94: 12303-12308
- PubMed: 9356444
- DOI: 10.1073/pnas.94.23.12303
- Also Cited By: 1CE0
- PubMed Abstract:
- Core Structure of Gp41 from the HIV Envelope Glycoprotein
Chan, D.C.,Fass, D.,Berger, J.M.,Kim, P.S.
(1997) Cell 89: 263
- Atomic Structure of the Ectodomain from HIV-1 Gp41
Weissenhorn, W.,Dessen, A.,Harrison, S.C.,Skehel, J.J.,Wiley, D.C.
(1997) Nature 387: 426
- A Trimeric Structural Domain of the HIV-1 Transmembrane Glycoprotein
Lu, M.,Blacklow, S.C.,Kim, P.S.
(1995) Nat.Struct.Mol.Biol. 2: 1075
Infection by HIV-1 involves the fusion of viral and cellular membranes with subsequent transfer of viral genetic material into the cell. The HIV-1 envelope glycoprotein that mediates fusion consists of the surface subunit gp120 and the transmembrane ...
Infection by HIV-1 involves the fusion of viral and cellular membranes with subsequent transfer of viral genetic material into the cell. The HIV-1 envelope glycoprotein that mediates fusion consists of the surface subunit gp120 and the transmembrane subunit gp41. gp120 directs virion attachment to the cell-surface receptors, and gp41 then promotes viral-cell membrane fusion. A soluble, alpha-helical, trimeric complex within gp41 composed of N-terminal and C-terminal extraviral segments has been proposed to represent the core of the fusion-active conformation of the HIV-1 envelope. A thermostable subdomain denoted N34(L6)C28 can be formed by the N-34 and C-28 peptides connected by a flexible linker in place of the disulfide-bonded loop region. Three-dimensional structure of N34(L6)C28 reveals that three molecules fold into a six-stranded helical bundle. Three N-terminal helices within the bundle form a central, parallel, trimeric coiled coil, whereas three C-terminal helices pack in the reverse direction into three hydrophobic grooves on the surface of the N-terminal trimer. This thermostable subdomain displays the salient features of the core structure of the isolated gp41 subunit and thus provides a possible target for therapeutics designed selectively to block HIV-1 entry.
Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.